Ian Berger1, Marshall Strother2,3, Ruchika Talwar2,3, Justin Ziemba2,3, Christopher Wirtalla4, Leilei Xia2,3, Thomas Guzzo2,3, M Kit Delgado5, Rachel Kelz4. 1. Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 2. Division of Urology, University of Pennsylvania, Philadelphia, Pennsylvania. 3. Perelman Center for Advanced Medicine West Pavilion, Philadelphia, Pennsylvania. 4. Center for Surgery and Health Economics, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania. 5. Department of Emergency Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract
PURPOSE: Prescription opioid use is increasing, leading to increased addiction and mortality. Postoperative care is often the first exposure to opioids of a patient but little data exist on national prescription patterns in urology. We examined post-discharge opioid fills after urological procedures and the association with long-term use. MATERIALS AND METHODS: We identified patients in a private national insurance database who underwent 1 of 15 urological procedures between October 1, 2010 and September 30, 2014. Patients with an opioid fill in the preceding 6 months were excluded from study. Claims for opioids from 30 days before the operation until 7 days after discharge characterized an initial prescription. Factors associated with persistent opioid use (an opioid claim 91 to 180 days after the operation) and chronic opioid use (10 or more refills of a 120-day or greater supply in the year after the operation) were analyzed using multivariable logistic regression. RESULTS: Overall 96,580 patients were included in study, of whom 49,391 (51%) filled an initial opioid prescription. Variation in the initial prescribed amount existed within procedures. Persistent use occurred in 6.2% of patients while chronic use occurred in 0.8%. Increased prescription in patients treated with transurethral prostate resection, vasectomy, female sling surgery, cystoscopy and stent insertion were associated with an increased risk of persistent as well as chronic use. CONCLUSIONS: National variation in opioid prescribing practice exists after urological operations. Patients who fill larger amounts of opioids after certain major and minor urological procedures are at increased risk for long-term opioid use. This provides evidence for procedure specific prescribing guidelines to minimize risk and promote standardization.
PURPOSE: Prescription opioid use is increasing, leading to increased addiction and mortality. Postoperative care is often the first exposure to opioids of a patient but little data exist on national prescription patterns in urology. We examined post-discharge opioid fills after urological procedures and the association with long-term use. MATERIALS AND METHODS: We identified patients in a private national insurance database who underwent 1 of 15 urological procedures between October 1, 2010 and September 30, 2014. Patients with an opioid fill in the preceding 6 months were excluded from study. Claims for opioids from 30 days before the operation until 7 days after discharge characterized an initial prescription. Factors associated with persistent opioid use (an opioid claim 91 to 180 days after the operation) and chronic opioid use (10 or more refills of a 120-day or greater supply in the year after the operation) were analyzed using multivariable logistic regression. RESULTS: Overall 96,580 patients were included in study, of whom 49,391 (51%) filled an initial opioid prescription. Variation in the initial prescribed amount existed within procedures. Persistent use occurred in 6.2% of patients while chronic use occurred in 0.8%. Increased prescription in patients treated with transurethral prostate resection, vasectomy, female sling surgery, cystoscopy and stent insertion were associated with an increased risk of persistent as well as chronic use. CONCLUSIONS: National variation in opioid prescribing practice exists after urological operations. Patients who fill larger amounts of opioids after certain major and minor urological procedures are at increased risk for long-term opioid use. This provides evidence for procedure specific prescribing guidelines to minimize risk and promote standardization.
Authors: Zachary J Prebay; Robert Medairos; Truman Landowski; Ross G Everett; Johnathan Doolittle; Jagan K Kansal; Kenneth Jacobsohn; Scott C Johnson Journal: J Robot Surg Date: 2021-01-25
Authors: Scott R Hawken; Spencer C Hiller; Stephanie Daignault-Newton; Khurshid R Ghani; John M Hollingsworth; Bronson Conrado; Conrad Maitland; David L Wenzler; John K Ludlow; Sapan N Ambani; Chad M Brummett; Casey A Dauw Journal: Urology Date: 2021-09-01 Impact factor: 2.649
Authors: Marieke J Krimphove; Stephen W Reese; Xi Chen; Maya Marchese; Daniel Pucheril; Eugene Cone; Wesley Chou; Karl H Tully; Adam S Kibel; Richard D Urman; Steven L Chang; Luis A Kluth; Prokar Dasgupta; Quoc Dien Trinh Journal: Investig Clin Urol Date: 2020-11-13
Authors: Anish K Agarwal; Daniel Lee; Zarina Ali; Brian Sennett; Ruiying Xiong; Jessica Hemmons; Evan Spencer; Dina Abdel-Rahman; Rachel Kleinman; Hannah Lacko; Annamarie Horan; Mary Dooley; Eric Hume; Samir Mehta; M Kit Delgado Journal: JAMA Netw Open Date: 2021-03-01